Log in to save to my catalogue

Efficacy and safety of mineralocorticoid receptor antagonists for the treatment of low-renin hyperte...

Efficacy and safety of mineralocorticoid receptor antagonists for the treatment of low-renin hyperte...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11076210

Efficacy and safety of mineralocorticoid receptor antagonists for the treatment of low-renin hypertension: a systematic review and meta-analysis

About this item

Full title

Efficacy and safety of mineralocorticoid receptor antagonists for the treatment of low-renin hypertension: a systematic review and meta-analysis

Publisher

London: Nature Publishing Group UK

Journal title

Journal of human hypertension, 2024-05, Vol.38 (5), p.383-392

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Hypertension is the leading risk factor for premature death. The optimal treatment of low-renin hypertension (LRH), present in 30% of hypertensive individuals, is not known. LRH likely reflects a state of excess salt, expanded volume and/or mineralocorticoid receptor (MR) activation. Therefore, targeted treatment with MR antagonists (MRA) may be be...

Alternative Titles

Full title

Efficacy and safety of mineralocorticoid receptor antagonists for the treatment of low-renin hypertension: a systematic review and meta-analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11076210

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11076210

Other Identifiers

ISSN

1476-5527,0950-9240

E-ISSN

1476-5527

DOI

10.1038/s41371-023-00891-1

How to access this item